Ixchiq
Ixchiq Recall Summary Ixchiq, a live chikungunya virus vaccine, is being recalled in the European Union due to adverse events and restrictions on its approved uses. The vaccine contains a weakened form of the chikungunya virus intended for immunization against chikungunya infection. This is a Class II recall affecting vaccine supplies distributed throughout the EU.
- Product
- Active substances: Chikungunya virus, strain CHIKV LR2006-OPY1, live attenuated. Therapeutic area: Chikungunya virus. ATC code: J07BP01
- Reason
- Adverse event;Restriction of indication
- Classification
- Class II
- Category
- drug recall
- Country
- European Union
- Agency
- EMA-DHPC
- Recall date
- 2026-07-14
- Status
- Ongoing
- Distribution
- European Union
Official recall notice from EMA-DHPC
Recall details on Nibble Recalls: https://trynibble.app/recalls/acab733a-d69c-4d48-ba7e-19f895b75833